Yifeng Pharmacy Chain Co Ltd
SSE:603939
Income Statement
Earnings Waterfall
Yifeng Pharmacy Chain Co Ltd
Revenue
|
22.4B
CNY
|
Cost of Revenue
|
-13.8B
CNY
|
Gross Profit
|
8.6B
CNY
|
Operating Expenses
|
-6.4B
CNY
|
Operating Income
|
2.2B
CNY
|
Other Expenses
|
-712m
CNY
|
Net Income
|
1.4B
CNY
|
Income Statement
Yifeng Pharmacy Chain Co Ltd
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||
Revenue |
2 230
N/A
|
2 373
+6%
|
2 492
+5%
|
2 615
+5%
|
2 846
+9%
|
3 039
+7%
|
3 305
+9%
|
3 539
+7%
|
3 734
+5%
|
3 978
+7%
|
4 210
+6%
|
4 480
+6%
|
4 807
+7%
|
5 211
+8%
|
5 562
+7%
|
6 054
+9%
|
6 913
+14%
|
7 900
+14%
|
8 967
+14%
|
9 636
+7%
|
10 276
+7%
|
10 855
+6%
|
11 521
+6%
|
12 324
+7%
|
13 145
+7%
|
13 726
+4%
|
14 198
+3%
|
14 646
+3%
|
15 326
+5%
|
15 845
+3%
|
16 730
+6%
|
17 736
+6%
|
19 886
+12%
|
21 004
+6%
|
21 843
+4%
|
22 427
+3%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(1 349)
|
(1 449)
|
(1 513)
|
(1 591)
|
(1 739)
|
(1 873)
|
(2 047)
|
(2 182)
|
(2 262)
|
(2 428)
|
(2 561)
|
(2 716)
|
(2 891)
|
(3 158)
|
(3 353)
|
(3 658)
|
(4 224)
|
(4 824)
|
(5 514)
|
(5 905)
|
(6 284)
|
(6 711)
|
(7 145)
|
(7 664)
|
(8 183)
|
(8 479)
|
(8 655)
|
(8 841)
|
(9 184)
|
(9 493)
|
(10 033)
|
(10 655)
|
(12 082)
|
(12 827)
|
(13 352)
|
(13 825)
|
|
Gross Profit |
881
N/A
|
924
+5%
|
979
+6%
|
1 025
+5%
|
1 107
+8%
|
1 167
+5%
|
1 258
+8%
|
1 358
+8%
|
1 471
+8%
|
1 550
+5%
|
1 649
+6%
|
1 764
+7%
|
1 916
+9%
|
2 053
+7%
|
2 209
+8%
|
2 396
+8%
|
2 689
+12%
|
3 077
+14%
|
3 453
+12%
|
3 731
+8%
|
3 992
+7%
|
4 144
+4%
|
4 376
+6%
|
4 660
+7%
|
4 961
+6%
|
5 247
+6%
|
5 542
+6%
|
5 805
+5%
|
6 143
+6%
|
6 352
+3%
|
6 697
+5%
|
7 081
+6%
|
7 805
+10%
|
8 177
+5%
|
8 491
+4%
|
8 601
+1%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Expenses |
(703)
|
(727)
|
(773)
|
(815)
|
(903)
|
(942)
|
(1 012)
|
(1 095)
|
(1 206)
|
(1 259)
|
(1 329)
|
(1 420)
|
(1 539)
|
(1 603)
|
(1 723)
|
(1 878)
|
(2 174)
|
(2 446)
|
(2 713)
|
(2 920)
|
(3 164)
|
(3 219)
|
(3 349)
|
(3 537)
|
(3 801)
|
(3 987)
|
(4 235)
|
(4 479)
|
(4 740)
|
(4 893)
|
(5 175)
|
(5 474)
|
(5 857)
|
(6 135)
|
(6 396)
|
(6 448)
|
|
Selling, General & Administrative |
(642)
|
(724)
|
(768)
|
(809)
|
(828)
|
(935)
|
(1 004)
|
(1 087)
|
(1 109)
|
(1 250)
|
(1 324)
|
(1 409)
|
(1 420)
|
(1 601)
|
(1 719)
|
(1 874)
|
(2 024)
|
(2 454)
|
(2 727)
|
(2 946)
|
(2 994)
|
(3 238)
|
(3 372)
|
(3 553)
|
(3 637)
|
(4 000)
|
(4 239)
|
(4 480)
|
(4 523)
|
(4 896)
|
(5 172)
|
(5 465)
|
(5 549)
|
(6 101)
|
(6 359)
|
(6 404)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(9)
|
(11)
|
0
|
(9)
|
(10)
|
(11)
|
(4)
|
(17)
|
(19)
|
(20)
|
(9)
|
(26)
|
(26)
|
(27)
|
|
Depreciation & Amortization |
(22)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(70)
|
0
|
0
|
0
|
(94)
|
0
|
0
|
0
|
(111)
|
0
|
0
|
0
|
(148)
|
0
|
0
|
0
|
(185)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(39)
|
(3)
|
(5)
|
(7)
|
(48)
|
(7)
|
(8)
|
(8)
|
(59)
|
(8)
|
(4)
|
(7)
|
(69)
|
0
|
(3)
|
(2)
|
(80)
|
8
|
14
|
27
|
(75)
|
26
|
32
|
28
|
(53)
|
22
|
13
|
13
|
(65)
|
20
|
16
|
12
|
(114)
|
(8)
|
(11)
|
(18)
|
|
Operating Income |
178
N/A
|
197
+11%
|
206
+4%
|
209
+1%
|
204
-2%
|
225
+10%
|
247
+10%
|
263
+7%
|
265
+1%
|
292
+10%
|
320
+10%
|
345
+8%
|
377
+9%
|
450
+19%
|
486
+8%
|
518
+7%
|
514
-1%
|
630
+23%
|
740
+17%
|
811
+10%
|
828
+2%
|
924
+12%
|
1 027
+11%
|
1 124
+9%
|
1 160
+3%
|
1 260
+9%
|
1 307
+4%
|
1 326
+1%
|
1 403
+6%
|
1 460
+4%
|
1 522
+4%
|
1 607
+6%
|
1 947
+21%
|
2 043
+5%
|
2 095
+3%
|
2 153
+3%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
Interest Income Expense |
7
|
1
|
8
|
14
|
29
|
23
|
18
|
18
|
31
|
29
|
39
|
41
|
54
|
33
|
48
|
39
|
49
|
27
|
(14)
|
(31)
|
(12)
|
(47)
|
(49)
|
(43)
|
9
|
(19)
|
(18)
|
(26)
|
(70)
|
(81)
|
(88)
|
(100)
|
(85)
|
(89)
|
(60)
|
(48)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(4)
|
(2)
|
(2)
|
0
|
15
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
2
|
4
|
5
|
8
|
11
|
17
|
13
|
26
|
33
|
32
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
7
|
6
|
6
|
7
|
7
|
8
|
9
|
6
|
10
|
11
|
9
|
6
|
1
|
(4)
|
(5)
|
(1)
|
3
|
3
|
2
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(3)
|
0
|
(2)
|
3
|
1
|
2
|
(9)
|
(12)
|
(11)
|
|
Pre-Tax Income |
191
N/A
|
204
+7%
|
219
+8%
|
230
+5%
|
240
+5%
|
255
+6%
|
272
+7%
|
287
+5%
|
306
+7%
|
330
+8%
|
366
+11%
|
391
+7%
|
428
+9%
|
478
+12%
|
527
+10%
|
556
+5%
|
581
+5%
|
658
+13%
|
727
+10%
|
778
+7%
|
814
+5%
|
874
+7%
|
974
+11%
|
1 076
+11%
|
1 164
+8%
|
1 237
+6%
|
1 286
+4%
|
1 301
+1%
|
1 338
+3%
|
1 384
+3%
|
1 447
+5%
|
1 526
+5%
|
1 877
+23%
|
1 971
+5%
|
2 056
+4%
|
2 126
+3%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||
Tax Provision |
(49)
|
(52)
|
(56)
|
(58)
|
(61)
|
(65)
|
(69)
|
(73)
|
(78)
|
(85)
|
(95)
|
(102)
|
(111)
|
(124)
|
(134)
|
(141)
|
(140)
|
(157)
|
(177)
|
(190)
|
(205)
|
(221)
|
(248)
|
(276)
|
(297)
|
(315)
|
(328)
|
(329)
|
(347)
|
(361)
|
(370)
|
(387)
|
(450)
|
(466)
|
(470)
|
(487)
|
|
Income from Continuing Operations |
142
|
152
|
163
|
171
|
178
|
190
|
203
|
214
|
228
|
245
|
271
|
289
|
317
|
353
|
394
|
415
|
442
|
502
|
550
|
588
|
609
|
653
|
726
|
800
|
867
|
921
|
958
|
972
|
991
|
1 023
|
1 077
|
1 139
|
1 427
|
1 505
|
1 586
|
1 639
|
|
Income to Minority Interest |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(8)
|
(10)
|
(13)
|
(25)
|
(39)
|
(51)
|
(62)
|
(65)
|
(70)
|
(82)
|
(89)
|
(99)
|
(103)
|
(97)
|
(98)
|
(103)
|
(104)
|
(117)
|
(123)
|
(162)
|
(175)
|
(191)
|
(198)
|
|
Net Income (Common) |
141
N/A
|
150
+6%
|
161
+8%
|
169
+5%
|
176
+4%
|
187
+6%
|
200
+7%
|
210
+5%
|
224
+7%
|
241
+8%
|
267
+11%
|
285
+7%
|
314
+10%
|
345
+10%
|
384
+11%
|
402
+5%
|
416
+3%
|
463
+11%
|
499
+8%
|
526
+5%
|
544
+3%
|
583
+7%
|
644
+10%
|
712
+11%
|
768
+8%
|
819
+7%
|
861
+5%
|
874
+2%
|
888
+2%
|
919
+3%
|
960
+4%
|
1 016
+6%
|
1 266
+25%
|
1 330
+5%
|
1 394
+5%
|
1 441
+3%
|
|
EPS (Diluted) |
0.32
N/A
|
0.3
-6%
|
0.27
-10%
|
0.29
+7%
|
0.3
+3%
|
0.32
+7%
|
0.34
+6%
|
0.36
+6%
|
0.34
-6%
|
0.36
+6%
|
0.42
+17%
|
0.44
+5%
|
0.47
+7%
|
0.52
+11%
|
0.58
+12%
|
0.61
+5%
|
0.63
+3%
|
0.69
+10%
|
0.73
+6%
|
0.76
+4%
|
0.79
+4%
|
0.84
+6%
|
0.93
+11%
|
1.03
+11%
|
1.12
+9%
|
1.18
+5%
|
1.23
+4%
|
1.17
-5%
|
0.89
-24%
|
1.28
+44%
|
1.33
+4%
|
0.99
-26%
|
1.26
+27%
|
1.32
+5%
|
1.38
+5%
|
1.42
+3%
|